Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A pilot study on pharmacokinetic/pharmacodynamic target attainment in critically ill patients receiving piperacillin/tazobactam

J. Martínková, ML. Malbrain, E. Havel, P. Šafránek, J. Bezouška, M. Kaška,

. 2016 ; 48 (1) : 23-28. [pub] 20151120

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17014217

Grantová podpora
NT14089 MZ0 CEP - Centrální evidence projektů

BACKGROUND: In critically ill patients, multi-trauma and intensive therapy can influence the pharmacokinetics (PK) and pharmacodynamics (PD) of antibiotics with time-dependent bacterial killing. Consequently, PK/PD targets (%fT>MIC) - crucial for antimicrobial effects -may not be attained. METHODS: Two patients admitted to the surgical ICU of the University Hospital in Hradec Králove for multiple-trauma were given piperacillin/tazobactam by 1-hour IV infusion 4/0.5 g every 8h. PK variables: total and renal clearance (CLtot, CLR), volume of distribution (Vd), and elimination half-life (T1/2) were calculated, followed by glomerular filtration rate (MDRD) and cumulative fluid balance (CFB-total fluid volume based on 24-h registered fluid intake minus output). The PK/PD target attainment (100%fT>MIC) was defined as free (f) piperacillin plasma concentrations that remain, during the entire dosing interval (T), above the minimum inhibitory concentration (100%fT>MIC) within days 4-8 (when CFB culminates and disappears). Piperacillin concentrations were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and corrected for unbound fraction (22%). RESULTS: CFB culminated over days 2-5 reaching 15-30 L and was associated with a large Vd (29-42 L). While MDRD in patient 1 was low (0.3-0.4 mL s⁻¹ 1.7 m⁻²), that of patient 2 was increasing (> 3.1 mL s⁻¹ 1.7 m⁻²), which was associated with augmented CLR. In patient 2, the fT reached only 62, 52, and 44% on days 4, 6, and 8, respectively. In patient 1, the %fT was much higher, attaining values four to fivefold greater than that targeted. CONCLUSIONS: Critically ill patients are at risk of drug under- or overdosing without dose up-titration with regard to covariate effects and individual drug pharmacokinetics.

000      
00000naa a2200000 a 4500
001      
bmc17014217
003      
CZ-PrNML
005      
20190114095332.0
007      
ta
008      
170413s2016 pl f 000 0|eng||
009      
AR
024    7_
$a 10.5603/AIT.a2015.0082 $2 doi
035    __
$a (PubMed)26588478
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Martínková, Jiřina
245    12
$a A pilot study on pharmacokinetic/pharmacodynamic target attainment in critically ill patients receiving piperacillin/tazobactam / $c J. Martínková, ML. Malbrain, E. Havel, P. Šafránek, J. Bezouška, M. Kaška,
520    9_
$a BACKGROUND: In critically ill patients, multi-trauma and intensive therapy can influence the pharmacokinetics (PK) and pharmacodynamics (PD) of antibiotics with time-dependent bacterial killing. Consequently, PK/PD targets (%fT>MIC) - crucial for antimicrobial effects -may not be attained. METHODS: Two patients admitted to the surgical ICU of the University Hospital in Hradec Králove for multiple-trauma were given piperacillin/tazobactam by 1-hour IV infusion 4/0.5 g every 8h. PK variables: total and renal clearance (CLtot, CLR), volume of distribution (Vd), and elimination half-life (T1/2) were calculated, followed by glomerular filtration rate (MDRD) and cumulative fluid balance (CFB-total fluid volume based on 24-h registered fluid intake minus output). The PK/PD target attainment (100%fT>MIC) was defined as free (f) piperacillin plasma concentrations that remain, during the entire dosing interval (T), above the minimum inhibitory concentration (100%fT>MIC) within days 4-8 (when CFB culminates and disappears). Piperacillin concentrations were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and corrected for unbound fraction (22%). RESULTS: CFB culminated over days 2-5 reaching 15-30 L and was associated with a large Vd (29-42 L). While MDRD in patient 1 was low (0.3-0.4 mL s⁻¹ 1.7 m⁻²), that of patient 2 was increasing (> 3.1 mL s⁻¹ 1.7 m⁻²), which was associated with augmented CLR. In patient 2, the fT reached only 62, 52, and 44% on days 4, 6, and 8, respectively. In patient 1, the %fT was much higher, attaining values four to fivefold greater than that targeted. CONCLUSIONS: Critically ill patients are at risk of drug under- or overdosing without dose up-titration with regard to covariate effects and individual drug pharmacokinetics.
650    _2
$a dospělí $7 D000328
650    _2
$a antibakteriální látky $x farmakokinetika $x farmakologie $7 D000900
650    12
$a kritický stav $7 D016638
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a lidé středního věku $7 D008875
650    _2
$a kyselina penicilanová $x analogy a deriváty $x farmakokinetika $x farmakologie $7 D010397
650    _2
$a pilotní projekty $7 D010865
650    _2
$a piperacilin $x farmakokinetika $x farmakologie $7 D010878
650    _2
$a prospektivní studie $7 D011446
650    _2
$a inhibitory beta-laktamasy $x farmakokinetika $x farmakologie $7 D065093
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Malbrain, Manu L N G
700    1_
$a Havel, Eduard
700    1_
$a Šafránek, Petr
700    1_
$a Bezouška, Jan
700    1_
$a Kaška, Milan $u Surgical Department, University Hospital, Hradec Králové, Czech Republic. kaskam@lfhk.cuni.cz.
773    0_
$w MED00011627 $t Anaesthesiology intensive therapy $x 1731-2515 $g Roč. 48, č. 1 (2016), s. 23-28
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26588478 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20190114095541 $b ABA008
999    __
$a ok $b bmc $g 1200682 $s 974995
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 48 $c 1 $d 23-28 $e 20151120 $i 1731-2515 $m Anestezjologia, Intensywna Terapia $n Anestezjol Intens Ter $x MED00011627
GRA    __
$a NT14089 $p MZ0
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...